-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that the Shanghai Stock Exchange issued a notice after the market on September 4. According to the relevant provisions of the “Shanghai Stock Exchange Shanghai-Hong Kong Stock Exchange Business Implementation Measures”, Yingpai Pharmaceutical (07630.HK) was officially transferred to the Hong Kong Stock Exchange's securities list. The adjustment will take effect on September 7 (Monday). This means that mainland investors can now directly trade Yingpai Pharmaceutical through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital.

Zhitongcaijing·09/04/2026 12:17:11
Listen to the news
The Zhitong Finance App learned that the Shanghai Stock Exchange issued a notice after the market on September 4. According to the relevant provisions of the “Shanghai Stock Exchange Shanghai-Hong Kong Stock Exchange Business Implementation Measures”, Yingpai Pharmaceutical (07630.HK) was officially transferred to the Hong Kong Stock Exchange's securities list. The adjustment will take effect on September 7 (Monday). This means that mainland investors can now directly trade Yingpai Pharmaceutical through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital.